title: Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia.
authors.affiliation: Abteilung Hämatologie und Onkologie, Medizinische Hochschule, Hannover. mkarthaus@gmx.de
authors.forename: M
authors.initials: M
authors.lastname: Karthaus
authors.forename: T
authors.initials: T
authors.lastname: Südhoff
authors.forename: G
authors.initials: G
authors.lastname: Egerer
authors.forename: K
authors.initials: K
authors.lastname: Fenchel
authors.forename: D
authors.initials: D
authors.lastname: Kämpfe
authors.forename: J
authors.initials: J
authors.lastname: Ritter
authors.forename: A
authors.initials: A
authors.lastname: Franke
authors.forename: G
authors.initials: G
authors.lastname: Heil
authors.forename: G
authors.initials: G
authors.lastname: Peters
authors.forename: H
authors.initials: H
authors.lastname: Jürgens
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D002443:Ceftriaxone / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008223:Lymphoma / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D002511:Cephalosporins; D002443:Ceftriaxone